Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase).
The peripheral conversion of testosterone to estradiol by aromatase is the primary source of endogenous estrogen in postmenopausal women. Studies indicating that placental aromatase is able to metabolize methadone to its primary metabolite, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidin (EDDP), led us to test the hypothesis that methadone is able to act as an inhibitor of aromatase. Using recombinant human CYP19, we examined the ability of methadone to bring about either reversible or mechanism-based inhibition of the conversion of testosterone to estradiol. To test for reversible inhibition, racemic methadone or its metabolite EDDP or 2-ethyl-5-methyl-3, 3-diphenylpyrroline (EMDP) was incubated for 30 min with testosterone at the K(m) (4 microM). To test for mechanism-based inhibition, microsomal preincubations were performed for up to 30 min using racemic methadone (1-1000 microM), R- or S-methadone (0.5-500 microM), or EDDP or EMDP (10 and 100 microM) followed by incubation with testosterone at a V(max) concentration (50 microM). Racemic methadone, EDDP, and EMDP did not act as competitive inhibitors of CYP19. Preincubation of methadone, EDDP, or EMDP with CYP19 resulted in time- and concentration-dependent inhibition, indicating a mechanism-based reaction that destroys CYP19 activity. The K(I) and k(inact) values for racemic methadone were calculated to be 40.6 +/- 2.8 microM and 0.061 +/- 0.001 min(-1), respectively. No stereoselectivity was observed. Methadone is metabolized by CYP19 and may act as a potent inhibitor of CYP19 in vivo. These findings may contribute to variability in methadone clearance, to drug-drug interactions, and to side effects observed in individual patients.
Lu
Wenjie Jessie
WJ
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. lu20@iupui.edu
Bies
Robert
R
Kamden
Landry K
LK
Desta
Zeruesenay
Z
Flockhart
David A
DA
D000701:Analgesics, Opioid / Q000378:metabolism / Q000494:pharmacology; D000728:Androgens / Q000378:metabolism; D001141:Aromatase / Q000378:metabolism*; D047072:Aromatase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D004958:Estradiol / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008691:Methadone / Q000378:metabolism* / Q000494:pharmacology*; D008861:Microsomes / Q000378:metabolism; D011759:Pyrrolidines / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
C103254:2-ethyl-5-methyl-3,3-diphenylpyrroline; D000701:Analgesics, Opioid; D000728:Androgens; D047072:Aromatase Inhibitors; D004967:Estrogens; D011759:Pyrrolidines; D011994:Recombinant Proteins; D013739:Testosterone; D004958:Estradiol; D001141:Aromatase; D008691:Methadone; C010724:2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
JAMA. 2008 Nov 19;300(19):2303-5
19017918
Drug Alcohol Depend. 2000 Dec 22;61(1):47-54
11064183
Am J Perinatol. 2006 Jul;23(5):287-94
16799915
Int J Androl. 2009 Apr;32(2):131-9
17971165
Curr Drug Metab. 2007 Jun;8(5):407-47
17584015
Clin Pharmacokinet. 2002;41(14):1153-93
12405865
Br J Clin Pharmacol. 2009 Jan;67(1):29-37
19133059
Am J Forensic Med Pathol. 1995 Jun;16(2):97-100
7572883
Biochem Pharmacol. 2006 Apr 14;71(8):1255-64
16455059
Br J Clin Pharmacol. 1999 Apr;47(4):403-12
10233205
Int J Addict. 1985 Jun-Jul;20(6-7):803-21
3908338
J Pharmacol Exp Ther. 2003 Sep;306(3):1099-105
12808001
Drug Metab Dispos. 2003 Jun;31(6):742-7
12756206
Anesthesiology. 2008 Mar;108(3):363-74
18292673
N Engl J Med. 2005 May 26;352(21):2211-21
15917386
Clin Pharmacol Ther. 2008 Oct;84(4):497-505
19238655
Ciba Found Symp. 1995;191:171-80; discussion 180-6
8582196
J Pharmacol Exp Ther. 1999 Sep;290(3):1116-25
10454485
Life Sci. 1981 May 11;28(19):2111-7
7253804
Pharmacotherapy. 2003 Jun;23(6):802-5
12820821
J Med Chem. 1971 Mar;14(3):194-7
5552207
Toxicology. 1997 Feb 14;117(1):13-23
9020195
J Pharmacol Exp Ther. 1985 Apr;233(1):1-6
3981450
J Biomed Inform. 2007 Aug;40(4):382-9
17185042
Drug Alcohol Depend. 2006 Dec 1;85(3):258-62
16860495
Acta Anaesthesiol Scand. 2008 Aug;52(7):879-89
18331375
Chem Res Toxicol. 2008 Jan;21(1):189-205
18052110
Clin Pharmacol Ther. 2004 Sep;76(3):250-69
15371986
J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):117-26
9365180
Pain Med. 2008 Apr;9(3):315-44
18386306
Anesthesiology. 2009 Mar;110(3):660-72
19225389
Indian J Pediatr. 2008 Sep;75(9):911-4
18584128
Biochem Pharmacol. 2004 Aug 1;68(3):583-91
15242824
Arch Biochem Biophys. 1981 Sep;210(2):717-28
7305355